ONCSM vs ECILC Comparison
Price, market cap, valuation, profitability and leverage metrics of ONCSM and ECILC side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ONCSM | ECILC | Sector median |
|---|---|---|---|
| Last price (TL) | 82.65 | 63.55 | 18.72 |
| Daily change | −7.24% | −7.23% | −6.36% |
| Market cap | TRY 2B | TRY 43.5B | TRY 4.3B |
| P/E | 26.70 | — | 17.35 |
| P/B | 4.21 | 0.68 | 1.09 |
| Dividend yield | — | 2.04% | 0.90% |
| Return on equity | 18.26% | −3.08% | 1.78% |
| Free float | 40.86% | 22.02% | 37.21% |
Popular Comparisons
Related Pages
About the ONCSM vs ECILC Comparison
Price, market cap, valuation multiples, profitability and leverage of ONCSM (Oncosem Onkolojik Sistemler) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 28, 2026, 14:18. Of the 15 metrics compared, ONCSM leads in 10 and ECILC leads in 5.
Highlights: Daily change: ECILC leads (−7.23% vs −7.24%). Market cap: ECILC leads (TRY 43.5B vs TRY 2B). P/B: ECILC leads (0.68 vs 4.21). EV/EBITDA: ONCSM leads (7.50 vs 165.19). EV/Sales: ONCSM leads (4.76 vs 9.35). Gross margin: ONCSM leads (54.30% vs 37.83%). EBITDA margin (annual): ONCSM leads (41.91% vs 11.49%). Net margin (annual): ONCSM leads (10.83% vs −20.86%).
Frequently Asked Questions
Is ONCSM or ECILC cheaper?
By P/E, Tie is cheaper (26.70 vs —); by P/B, ECILC trades at the lower multiple (4.21 vs 0.68).
Which is more profitable, ONCSM or ECILC?
Annual net margin is 10.83% for ONCSM and −20.86% for ECILC; return on equity is 18.26% for ONCSM and −3.08% for ECILC.
Which is more leveraged, ONCSM or ECILC?
The leverage ratio is 44.59 for ONCSM and 18.92 for ECILC; net debt/EBITDA is 0.48 for ONCSM and 1.37 for ECILC. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.